Health secretary announces 10-year plan for dementia
May 18, 2022Research and Development
Sajid Javid has announced plans to work across the government to boost the £375 million that is already committed for …
Study investigating VR treatment for chronic pain
May 18, 2022Research and Development
AppliedVR and Kernel have partnered for a randomised study comparing the effect of AppliedVR’s FDA-authorised, VR-based program, RelieVRx, versus a …
More monkeypox cases detected in England
May 18, 2022Research and Development
The UK Health Security Agency (UKHSA) says the risk presented by monkeypox to the public remains very low, though it …
Vaccine for rare but deadly mosquito-borne viruses in clinical trial
May 17, 2022Sales and Marketing
Positive results for a vaccine for eastern equine encephalitis virus (EEEV), western equine encephalitis virus (WEEV), and Venezuelan equine encephalitis …
Evotec and Sernova collaborate into beta cell replacement therapy for diabetes
May 17, 2022Medical Communications
Evotec and Sernova have announced an exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a ‘functional cure’ …
Study launched to investigate COVID-19 vaccine in young immunocompromised
May 17, 2022Manufacturing and Production
The UK’s largest kidney research charity has announced the launch of a study into the protection offered by COVID-19 vaccines …
Breast cancer ‘metal detector’ recommended to NHS
May 17, 2022Medical Communications
A recommendation by the government’s health advisers have said that women with invasive breast cancer could be injected with a …
Eli Lilly’s diabetes treatment wins FDA approval
May 16, 2022Sales and Marketing
Eli Lilly’s once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide has won FDA approval.The FDA …
NHS prescription charges in England to be frozen for first time in 12 years
May 16, 2022Sales and Marketing
The Department of Health has said that single prescription charges, which normally rise “in line with inflation”, will remain at …
Imfimzi for routine use on NHS England for patients with stage III unresectable lung cancer
May 16, 2022Sales and Marketing
AstraZeneca has announced the NICE recommendation of Imfinzi (durvalumab) for routine use within NHS England as a monotherapy for the …
Researchers pinpoint reason for Sudden Infant Deaths
May 16, 2022Sales and Marketing
Scientists from The Children’s Hospital Westmead in Sydney have discovered that babies who died of sudden infant death syndrome (SIDS) …
60,000 NHS staff believed to suffer pandemic-related PTSD
May 13, 2022Medical Communications
As many as 60,000 NHS staff are believed to be suffering from post-traumatic stress brought on by the COVID-19 pandemic, …
New national guidance addressing sepsis
May 13, 2022Medical Communications
New guidelines proposing significant changes to the way people with suspected sepsis are treated with antibiotics have been published. The …
Plant-based COVID-19 vaccine demonstrates 70% efficacy
May 12, 2022Business Services
The vaccine was developed by researchers at Canadian biotechnology company Medicago, and it contains coronavirus-like particles (CoVLP) produced in plants, …
Hypertensive pregnancy disorders linked to future cardiac events
May 12, 2022Business Services
A study funded by the US National Institutes of Health (NIH) has explained factors linked to increased risk for heart …
Phase III trial reveals positive results for Crohn’s disease treatment
May 12, 2022Business Services
AbbVie has announced positive topline results from U-ENDURE, its Phase III maintenance study, evaluating upadacitinib in adult patients with Crohn’s …
FDA approve Lilly-Incyte’s treatment for hospitalised COVID patients
May 12, 2022Business Services
The FDA has granted approval for Eli Lilly and Incyte’s Olumiant (baricitinib) to treat COVID-19 in adult patients admitted to …
SMC accepts chemotherapy-free VENCLYXTO for leukaemia treatment
May 11, 2022Research and Development
The SMC has accepted venetoclax in combination with obinutuzumab, for use within NHS Scotland, as a first-line treatment for patients …
Europe’s first psychedelic drug trial clinic to open in London
May 11, 2022Research and Development
British startup Clerkenwell Health aims to make the UK a global leader in psychedelic research and innovation, with Europe’s first …
Partnership researching genetics and treatments of long COVID
May 11, 2022Research and Development
PrecisionLife Limited have announced a partnership with Sano Genetics, a genetic research platform enabling patients to participate in ethical research …
